Data and biomaterial as a foundation for follow-up research
CPCT collects clinical data and biological material from thousands of patients. Researchers can request these data for scientific research that contributes to a better approach to cancer.
Starting new research with CPCT
In recent years CPCT has focused on patients with metastatic disease, regardless of the original tumor origin. This has resulted in a database of more than 8,000 patients. Alongside exploring existing clinical and genomic data, the next step is to design follow-up studies.
CPCT aims to be the platform for oncology precision-medicine studies. Get in touch via info@cpct.nl.
Hartwig Medical database
Data from the CPCT-02 and DRUP studies is included in the Hartwig Medical Foundation database. It contains whole genome sequencing (WGS) data linked to coded clinical data of more than 8,000 patients, one of the largest pan-cancer WGS datasets in the world. More information: hartwigmedicalfoundation.nl/data/databank.
Requesting data
All data are accessible to researchers in the Netherlands. Requests are reviewed by the independent scientific council and the Data Access Board of Hartwig Medical Foundation. Researchers sign a license agreement.
Full procedure: hartwigmedicalfoundation.nl/data/databank.
Requesting residual biomaterial (CPCT-02)
For many patients in the CPCT-02 study, biological material remains after sequencing: biopsies, isolated DNA and RNA, blood and/or plasma, stored in the CPCT biobank.
Complete the request form and send it to info@cpct.nl. Release takes place after review and signing of a Material Transfer Agreement (MTA).
CPCT publication policy (v3.0)
Acknowledgement. If a publication is generated using CPCT material or data, the following text is added: "Deze publicatie en het onderliggende onderzoek zijn mede mogelijk gemaakt op basis van de gegevens die het Center of Personalized Cancer Treatment (CPCT) beschikbaar heeft gesteld voor dit onderzoek."
Presentation and interpretation. The applicant contacts CPCT at an early stage and provides a copy of the proposed publication at least two weeks before submission.
Ethical standards. Applicants comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (ICMJE).